Private equity investors are still cautious about investing in serious mental illness (SMI) care due to the challenges associated with the population. However, venture capital firms may be more willing to invest in innovative SMI care models. Despite the hesitation, the economic cost of SMI is more than $300 billion each year. PE investors typically prefer models and organizations with a proven track record and that can scale easily, which can be challenging for SMI care. Many investors focus on the lower-acuity side of care, which doesn’t face the same challenges as SMI care. Additionally, reimbursement is a critical factor in SMI investment as people with SMI are over-represented in the Medicaid space. Traditionally, PE-backed companies have focused on commercial payers. However, some PE investors are becoming more comfortable with Medicaid-heavy businesses. On the other hand, venture capital firms may be better suited to invest in SMI care due to the need for new care models. Several venture-backed startups have emerged in the SMI care space, and some venture capitalists see this area as prime for innovation. GV, formerly Google Ventures, has already invested in new types of SMI care, including a New York-based startup that focuses on the peer-support model. The future of SMI investment may lie in venture capital rather than private equity.
Venture Capital’s Readiness to Pounce on Mental Illness Investment
Latest from Blog
Maximizing Venture Capital Funding: Are You in the 19%?
TLDR: Most startups struggle to raise venture capital due to growth issues. Only 19% of surveyed respondents said they should have raised more VC funding. In a recent survey of over 1,000
Noki Noki Secures $3 Million Investment for Logistics Expansion
TLDR: Congolese logistics company Noki Noki secures $3 million in seed funding The funding will be used to expand operations and enter new markets A Congolese logistics firm, Noki Noki, has raised
Innovation Unleashed: NLC Health Ventures debuts groundbreaking biotech startup
TLDR: Amsterdam-based NLC Health Ventures and Alphabet’s healthtech company Verily have launched a new biotech startup called Exolvo Biosciences. Exolvo aims to improve drug delivery technology for biologic drugs, making treatments more
Tech Startup Aquila Raises $2M for Wireless Power Innovation
TLDR: Aquila, a wireless power startup, raised $2 million in funding led by Alua Group. The startup aims to develop optical power-beaming technology to charge drones wirelessly. Aquila, a deep tech startup
UBS to sell large stake in securities venture to Beijing
“`html TLDR: UBS is selling a partial stake in a securities joint venture to Beijing State-owned Asset Management (BSAM). The stake sale is part of UBS’s consolidation efforts in China after its